Alzheimer Disease
Disease State Hub
Featured
04/24/2024
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
04/24/2024
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
04/15/2024
Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
04/15/2024
Interactive Features
03/29/2024
How reluctant are patients to see a doctor when they notice cognitive issues? Take this pop quiz to test your knowledge!
03/29/2024
02/22/2024
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
02/22/2024
12/26/2023
Epilepsy is often genetic and can be passed on to children. Do you believe genetic testing has a role in epilepsy management? Take our poll to voice your opinion!
12/26/2023
12/02/2023
Your patient is a 46-year-old woman with a family history of dementia and obesity. Based on her family history, she asks you if there is a way to reduce her risk of developing dementia, and a way to stay...
12/02/2023
11/11/2023
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
11/11/2023
Clinical Insights
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
04/14/2024
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
Samar R El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
03/25/2024
Brenden P. Lucey, MD, MSCI
Brenden P. Lucey, MD, MSCI
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
03/14/2024
Sri Banerjee, MD, PhD, MPH, MAS
Sri Banerjee, MD, PhD, MPH, MAS
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses the impact of diabetes on Alzheimer disease-related dementia mortality among Black Americans, including the burden and pathophysiology of...
03/14/2024
02/04/2024
In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...
02/04/2024
